472 related articles for article (PubMed ID: 15129904)
21. Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Lung Cancer; 1999 Apr; 24(1):11-6. PubMed ID: 10403689
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer.
Katakura H; Tanaka F; Oyanagi H; Miyahara R; Yanagihara K; Otake Y; Wada H
Ann Thorac Surg; 2002 Apr; 73(4):1060-4. PubMed ID: 11996241
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
[TBL] [Abstract][Full Text] [Related]
24. [The regulation of nm23-H1/NDPK-A in different processes of regional lymph node metastases of oral squamous cell carcinomas].
Yang Z; Wen Y; Pu P
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Aug; 21(4):263-6. PubMed ID: 14513578
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
26. Expression of nm23 protein in pulmonary adenocarcinomas: inverse 1orrelation to tumor progression.
Kawakubo Y; Sato Y; Koh T; Kono H; Kameya T
Lung Cancer; 1997 May; 17(1):103-13. PubMed ID: 9194030
[TBL] [Abstract][Full Text] [Related]
27. The NM23 gene and its expression in oral squamous cell carcinoma.
Lo Muzio L; Mignogna MD; Pannone G; Staibano S; Procaccini M; Serpico R; De Rosa G; Scully C
Oncol Rep; 1999; 6(4):747-51. PubMed ID: 10373649
[TBL] [Abstract][Full Text] [Related]
28. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
29. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
30. [The correlation between lung cancer lymph node metastasis and nm23-H1 gene mutation, mRNA expression].
Wang G; Du C; Lin Q
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):340-3. PubMed ID: 10374442
[TBL] [Abstract][Full Text] [Related]
31. The intratumoral microvessel density and expression of bFGF and nm23-H1 in colorectal cancer.
Elagoz S; Egilmez R; Koyuncu A; Muslehiddinoglu A; Arici S
Pathol Oncol Res; 2006; 12(1):21-7. PubMed ID: 16554912
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
Huang Y; Cai S; Yu S
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
Tran TA; Kallakury BV; Ambros RA; Ross JS
Cancer; 1998 Jul; 83(2):276-82. PubMed ID: 9669810
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
[TBL] [Abstract][Full Text] [Related]
35. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
36. Identification of nm23-H1 as a metastatic suppressor and prognostic factor in nasopharyngeal carcinoma by proteomic analysis.
Li X; Hu R; Qu J; He Q; Chen Y; Li J; Ye X; Xiang Y; Yi H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):17-26. PubMed ID: 22349375
[TBL] [Abstract][Full Text] [Related]
37. Immunohistologic detection of nm23-H1 protein in squamous cell carcinoma of the vulva.
Hantschmann P; Beysiegel S; Assemi C; Kurzl R
J Reprod Med; 2004 Oct; 49(10):787-95. PubMed ID: 15568401
[TBL] [Abstract][Full Text] [Related]
38. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.
Tomita M; Ayabe T; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
BMC Cancer; 2001; 1():3. PubMed ID: 11319942
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
Kuo JY; Chiang H; Chen KK; Chang LS
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):411-7. PubMed ID: 10418173
[TBL] [Abstract][Full Text] [Related]
40. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
